VKH
BLUE

Virtu KCG Holdings’s bluebird bio BLUE Stock Holding History

Virtu KCG Holdings’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,872
Closed -$1.5M – 3140
2016
Q4 		$1.5M Buy
1,872
+1,640
+707% +$1.3M 0.04% 474
2016
Q3 		$204K Buy
+232
New +$168K ﹤0.01% 2340
2015
Q4 		– Sell
-653
Closed -$724K – 3499
2015
Q3 		$724K Buy
653
+293
+81% +$534K 0.01% 1162
2015
Q2 		$785K Buy
360
+103
+40% +$210K 0.01% 1075
2015
Q1 		$402K Buy
+257
New +$339K 0.01% 1586
2014
Q3 		– Sell
-429
Closed -$214K – 3593
2014
Q2 		$214K Buy
+429
New +$138K ﹤0.01% 2987

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Virtu KCG Holdings's BLUE Position: Q1 2017 in Review

Virtu KCG Holdings sold out of bluebird bio (BLUE) in Q1 2017, closing a stake of 1,872 shares — an estimated $1.5M sold.

Virtu KCG Holdings first reported a position in BLUE in Q2 2014 and held it in 6 quarters. The position peaked at $1.5M in Q4 2016. 210 funds tracked by Wall St. Rank hold BLUE as of Q1 2017.

  • Virtu KCG Holdings reported no remaining bluebird bio position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 1,872 bluebird bio shares in Q1 2017, an estimated $1.5M.
  • Virtu KCG Holdings first reported a position in bluebird bio in Q2 2014 and held it in 6 quarters.
  • Virtu KCG Holdings's bluebird bio position peaked at $1.5M in Q4 2016.
  • 210 funds tracked by Wall St. Rank held bluebird bio as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.